The anti-inflammatory pharmacologic profile of CGP 28237 (5-methylsulfonylamino-6-phenoxy-1-indanone).
D000210:Acute-Phase Reaction / Q000188:drug therapy; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal; D001169:Arthritis, Experimental / Q000188:drug therapy / Q000517:prevention & control; D001327:Autoimmune Diseases / Q000188:drug therapy; D004064:Digestive System / Q000187:drug effects; D005260:Female; D007189:Indans / Q000494:pharmacology* / Q000633:toxicity; D007192:Indenes / Q000494:pharmacology*; D008297:Male; D051379:Mice; D051381:Rats
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007189:Indans; D007192:Indenes; C054253:5-methylsulfonylamino-6-phenoxy-1-indanone